Patent · US Active

Respiratory formulations and compounds for use therein

US8933228B2 · kind B2 · utility

39Cited by
2References
35Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 17, 2011
Grant dateJan 13, 2015
Priority date
Expiry dateJun 17, 2031

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10T428/2982
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to respiratory formulations comprising a compound of formula (I): and use of said compounds and compositions in treatment, for example in the treatment of an inflammatory disease or a respiratory disorder, in particular an inflammatory mediated and/or virally mediated respiratory disorder such as asthma and COPD or the treatment or prevention of viral infection, for example infection by influenza virus, rhinovirus or RSV. The invention also extends to certain novel compounds of formula (I).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.